¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"REC"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • recurrent artery
    µÇµ¹À̵¿¸Æ, ¹Ýȸµ¿¸Æ
  • recurrent attack
    ¹Ýº¹¹ßÀÛ
  • recurrent bandage
    ¹ÝȸºØ´ë
  • recurrent cancer
    Àç¹ß¾Ï
  • recurrent dislocation
    Àç¹ßÅ»±¸
  • recurrent fever
    Àç¹ß¿­
  • recurrent inhibition
    ȸ±Í¾ïÁ¦
  • recurrent interosseous artery
    »À»çÀ̵ǵ¹À̵¿¸Æ, ¹Ýȸ°ñ°£µ¿¸Æ
  • recurrent laryngeal nerve
    µÇµ¹ÀÌÈĵνŰæ, ¹ÝȸÈĵνŰæ
  • recurrent ophthalmoplegia
    ¹Ýº¹´«±ÙÀ°¸¶ºñ
  • recurrent projection
    ȸ±ÍÅõ»ç
  • recurrent reaction
    Àç¹ß¹ÝÀÀ
  • recurrent sensibility
    ȸ±Í°¨°¢
  • recurrent stricture
    Àç¹ßÇùÂø
  • recurrent subluxation
    Àç¹ß¾ÆÅ»±¸
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • rectum
    °ðâÀÚ, Á÷Àå
  • rectus
    °ðÀº-, Á÷
  • rectus abdominis muscle
    ¹è°ðÀº±Ù, º¹Á÷±Ù
  • rectus abdominis muscle flap
    ¹è°ðÀº±ÙÆÇ, º¹Á÷±ÙÆÇ
  • rectus capitis muscle
    ¸Ó¸®°ðÀº±Ù
  • rectus femoris muscle
    ³Ò´Ù¸®°ðÀº±Ù, ´ëÅðÁ÷±Ù
  • rectus femoris muscle flap
    ³Ò´Ù¸®°ðÀº±ÙÆÇ, ´ëÅðÁ÷±ÙÆÇ
  • rectus muscle
    °ðÀº±Ù
  • rectus sheath
    ¹è°ðÀº±ÙÁý
  • recumbent
    ´©À½-
  • recumbent position
    ¸ð·Î´©¿îÀÚ¼¼, Ⱦ¿ÍÀ§
  • recurrence
    Àç¹ß
  • recurrence risk
    Àç¹ßÀ§Çèµµ
  • recurrent
    Àç¹ß-, ȸ±Í
  • recurrent aphtha
    Àç¹ß¾ÆÇÁŸ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • rectal abscess
    Á÷Àå³ó¾ç(Á÷Àå³ó¾ç).
  • rectal abscess
    Á÷Àå³ó¾ç(òÁíóÒÛåË)
  • rectal aerophagia
    Á÷Àå³»°ø±âÈíÀÔ(¡­³»°ø±âÈíÀÔ).
  • rectal aganglionosis
    °ðâÀڽŰæÀý°á¿©Áõ
  • rectal alimentation
    Á÷À念¾ç¹ý(¡­¿µ¾ç¹ý).
  • rectal ampulla
    °ðâÀÚÆØ´ë
  • rectal ampulla ³ª a. recti
    Á÷À寨´ë, Á÷À寨´ëºÎ(òÁíóø³ÓÞÝ»).
  • rectal anesthesia
    Á÷À帶Ãë(¹ý)(¡­Ø«ö­Ûö).
  • rectal anesthetic
    Á÷À帶ÃëÁ¦<¾à>.
  • rectal application
    Á÷Àå³»Àû¿ë(¡­³»Àû¿ë).
  • rectal atresia
    Á÷ÀåÆó¼â(Á÷ÀåÆó¼â).
  • rectal atresia ³ª
    Á÷ÀåÆó¼â(¡­øÍáð)
  • rectal bleeding =archorragia
    Á÷ÀåÃâÇ÷(Á÷ÀåÃâÇ÷).
  • rectal bleeding =archorragia
    Á÷ÀåÃâÇ÷(¡­õóúì)
  • rectal bleeding, radiation induced
    ¹æ»ç¼±À¯¹ß Á÷ÀåÃâÇ÷
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • recombination
    Àç°áÇÕ(î¢Ì¿ùê).
  • recombination
    ÀçÁ¶ÇÕ.
  • recombination correction
    Àç°áÇÕ±³Á¤
  • recombination fraction
    ÀçÁ¶Çպмö(î¢ðàùêÝÂâ¦)
  • recombination frequency
    ÀçÁ¶ÇÕºóµµ
  • recombination rate
    Àç°áÇÕ·ü(¡­ëÒ).
  • recombination value
    Àç°áÇÕ°ª.
  • recombination, gene
    À¯ÀüÀÚÀçÁ¶ÇÕ
  • recombination, high frequency (Hfr)
    °íºóµµÀçÁ¶ÇÕ
  • recombination, illegitimate
    ºñÁ¤±ÔÀçÁ¶ÇÕ
  • recombinational repair
    ÀçÁ¶ÇÕ(¼º) DNAº¹±¸
  • recommended dietary allowance
    ¿µ¾ç±ÇÀå·®(ç½å×ÏèíáåÖ).
  • recommended dietary allowance
    À½½Ä¹°±ÇÀå·®.
  • recomposition
    ÀçÁ¶¼º(î¢ðãà÷), À籸¼º(î¢Ï°à÷).
  • recompression
    Àç°¡¾Ð(î¢Ê¥äâ).
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
receptors, transferrin Membrane glycoproteins found in high concentrations on iron-utilizing cells. They specifically bind iron-bearing transferrin, are endocytosed with its ligand and then returned to the cell surface where transferrin without its iron is released.
(12 Dec 1998)
receptors, transforming growth factor beta Cell-surface proteins that bind transforming growth factor beta and trigger changes influencing the behaviour of cells. Two types of transforming growth factor receptors have been recognised. They differ in affinity for different members of the transforming growth factor beta family and in cellular mechanisms of action. Transforming growth factor alpha binds to the same receptors as epidermal growth factor (see receptors, epidermal growth factor-urogastrone).
(12 Dec 1998)
receptors, tumour necrosis factor Cell surface receptors that bind tumour necrosis factor and trigger changes which influence the behaviour of cells. The two recognised tumour necrosis factor receptors are designated alpha and beta receptors. Both receptors bind both alpha and beta tumour necrosis factors with high affinity, and both are members of the nerve growth factor receptor family.
(12 Dec 1998)
receptors, vasoactive intestinal peptide Cell surface proteins that bind vasoactive intestinal peptide (vip) with high affinity and trigger intracellular changes which influence the behaviour of cells.
(12 Dec 1998)
receptors, vasopressin Specific molecular sites or structures on or in cells that vasopressins react or to which they bind in order to modify the function of the cells. Two types of vasopressin receptor exist, the v1 receptor and the v2 receptor. The v1 receptor can be subdivided into v1a and v1b (formerly v3) receptors.
(12 Dec 1998)
receptors, very late antigen Members of the integrin family appearing late after T-cell activation. They are a family of proteins initially identified at the surface of stimulated T-cells, but now identified on a variety of cell types. At least six vla antigens have been identified as heterodimeric adhesion receptors consisting of a single common beta-subunit and different alpha-subunits.
(12 Dec 1998)
receptors, virus Specific molecular components of the cell capable of recognizing and interacting with a virus, and which, after binding it, are capable of generating some signal that initiates the chain of events leading to the biological response.
(12 Dec 1998)
receptors, vitronectin Alpha-v beta-3 integrins that bind vitronectin with high affinity and play a role in cell migration. They also bind fibrinogen, von willebrand factor, osteopontin, and thrombospondin. The highly homologous alpha-v beta-5 integrin also binds vitronectin, but mediates simple adhesion.
(12 Dec 1998)
receptosomes Vesicles that avoid lysosomes and deliver their contents to other intracellular sites.
(05 Mar 2000)
recess 1. A withdrawing or retiring; a moving back; retreat; as, the recess of the tides. "Every degree of ignorance being so far a recess and degradation from rationality." (South) "My recess hath given them confidence that I may be conquered." (Eikon Basilike)
2. The state of being withdrawn; seclusion; privacy. "In the recess of the jury they are to consider the evidence." (Sir M. Hale) "Good verse recess and solitude requires." (Dryden)
3. Remission or suspension of business or procedure; intermission, as of a legislative body, court, or school. "The recess of . . . Parliament lasted six weeks." (Macaulay)
4. Part of a room formed by the receding of the wall, as an alcove, niche, etc. "A bed which stood in a deep recess." (W. Irving)
5. A place of retirement, retreat, secrecy, or seclusion. "Departure from his happy place, our sweet Recess, and only consolation left." (Milton)
6. Secret or abstruse part; as, the difficulties and recesses of science.
7. <botany> A sinus.
Origin: L. Recessus, fr. Recedere, recessum. See Recede.
Source: Websters Dictionary
(01 Mar 1998)
recession A withdrawal or retreating.
See: retraction.
Origin: L. Recessio (see recessus)
(05 Mar 2000)
recessitivity The state of being recessive.
(05 Mar 2000)
recessive <genetics> An allele or mutation that is only expressed phenotypically when it is present in the homozygous form. In the heterozygote it is obscured by dominant alleles.
(18 Nov 1997)
recessive character An inherited character determined by an allele in homozygous state only.
See: dominance of traits.
(05 Mar 2000)
recessive gene A gene that is expressed onlywhen it is present in two copies or if theother copy is missing.
(09 Oct 1997)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 14
  • Receptor, PAR-1 - »õâ A thrombin receptor subtype that couples to HETEROTRIMERIC GTP-BINDING PROTEINS resulting in the activation of a variety of signaling mechanisms including decreased intracellular CYCLIC AMP, increased PHOSPHOLIPASE C and increased PHOSPHOLIPASE A2.
    Synonyms : PAR1 Receptor, Proteinase-Activated Receptor 1, PAR 1 Receptor, Protease Activated Receptor 1, Proteinase Activated Receptor 1, Receptor, PAR 1, Receptor, PAR1
  • Receptor, PAR-2 - »õâ A G-protein-coupled, proteinase-activated receptor that is expressed in a variety of tissues including ENDOTHELIUM; LEUKOCYTES; and the GASTROINTESTINAL TRACT. The receptor is activated by TRYPSIN, which cleaves off the N-terminal peptide from the receptor. The new N-terminal peptide is a cryptic ligand for the receptor. The uncleaved receptor can also be activated by the N-terminal peptide present on the activated THROMBIN RECEPTOR and by small synthetic peptides that contain the unmasked N-terminal sequence.
    Synonyms : PAR2 Receptor, Protease-Activated Receptor 2, Receptor, Trypsin, Trypsin Receptor, Trypsin Receptors, PAR 2 Receptor, Protease Activated Receptor 2, Receptor 2, Protease-Activated, Receptor, PAR 2, Receptor, PAR2, Receptors, Trypsin
  • Receptor, Parathyroid Hormone, Type 1 - »õâ A parathyroid hormone receptor subtype that recognizes both PARATHYROID HORMONE and PARATHYROID HORMONE-RELATED PROTEIN. It is a G-protein-coupled receptor that is expressed at high levels in BONE and in KIDNEY.
    Synonyms : PTH-PTHrP Receptor, PTH-Related Peptide Receptor, PTH-Related Protein Receptor, PTHLP Receptor, PTHrP Receptor, Parathyroid Hormone Receptor, Parathyroid Hormone Receptor 1, Parathyroid Hormone Receptor Type I, Parathyroid Hormone-Like Peptide Receptor
  • Receptor, Parathyroid Hormone, Type 2 - »õâ A parathyroid hormone receptor subtype found in the BRAIN and the PANCREAS. It is a G-protein-coupled receptor with a ligand specificity that varies between homologs from different species.
    Synonyms : PTH-2 Receptor, PTH2 Receptor, PTH 2 Receptor, Receptor, PTH-2, Receptor, PTH2
  • Receptor, Platelet-Derived Growth Factor alpha - »õâ A PDGF receptor that binds specifically to both PDGF-A chains and PDGF-B chains. It contains a protein-tyrosine kinase activity that is involved in SIGNAL TRANSDUCTION.
    Synonyms : CD140a Antigen, PDGFR2, PDGFRalpha, Antigen, CD140a, Platelet Derived Growth Factor alpha Receptor
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
receptor A molecule on the surface of a cell that serves as a recognition or binding site for antigens, antibodies, or other cellular or immunological components.
Ãâó: www.amfar.org/cgi-bin/iowa/bridge.html
recombinant An organism whose genome contains integrated genetic material from a different organism. Also used in relation to compounds produced by laboratory or industrial cultures of genetically engineered living cells. The cells' genes have been altered to give the capability of producing large quantities of the desired compound for use as a medical treatment. Recombinant compounds are often altered versions of naturally occurring substances.
Ãâó: www.amfar.org/cgi-bin/iowa/bridge.html
recapitulation The theory that "ontogeny recapitulates phylogeny."
Ãâó: www.modernhumanorigins.com/r.html
recon A term coined by Seymour Benzer for the smallest recombinable unit within a cistron. A region of a gene within which there can be no crossing-over; now known to be a single nucleotide pair.
Ãâó: helios.bto.ed.ac.uk/bto/glossary/qr.htm
recombinant DNA DNA molecules in which sequences, not normally contiguous, have been placed next to each other by in vitro methods. (10)
Ãâó: ppathw3.cals.cornell.edu/glossary/Defs_R.htm
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • recognizant
    ÀÎÁ¤ÇÏ´Â;ÀǽÄÇÏ´Â
  • recognize
    ÀÎÁ¤ÇÏ´Ù,ÀλöÇÏ´Ù
  • recognize
    ÀÎÁ¤ÇÏ´Ù(acknowledge);ÀÎÁöÇÏ´Ù;¾Ë¾Æº¸´Ù;½ÂÀÎÇÏ´Ù;Àΰ¡(°øÀÎ)ÇÏ´Ù;(³²ÀÇ ¼ö°í µîÀ»)¾Ë¾ÆÁÖ´Ù;ǥâÇÏ´Ù;°¨»çÇÏ´Ù;º» ±â¾ïÀÌ ÀÖ´Ù;(º¸°í)»ý°¢ÇØ ³»´Ù;(¾Ë¾Æº¸°í)ÀλçÇÏ´Ù(salute);ÀÎÁöÇÏ´Ù;¹ß¾ð±ÇÀ» ÀÎÁ¤ÇÏ´Ù;¹ß¾ðÀ» Çã°¡ÇÏ´Ù;¼­¾à Áõ¼­(º¸¼®Áõ)¸¦ Á¦ÃâÇÏ´Ù;¼­¾àÇÏ´Ù;-nizer
  • recognizee
    ¼­¾àÀ» ¹Þ´Â »ç¶÷;¼ö¼­¾àÀÚ
  • recognizor
    ¼­¾àÀÚ
  • recoil
    ÁÖÃãÇÏ´Ù; µÇÆ¢´Ù; ¹Ýµ¿ÇÏ´Ù
  • recoil
    µÇÆ¢´Ù;µÚ·Î ¹°·¯°¡´Ù;µÇµ¹¾Æ ¿À´Ù;µÚ·Î ¹Ýµ¿ÇÏ´Ù;(ÃÑÆ÷ÀÇ ¹ß»ç ÈÄ);ÈÄÅð(ÆÐÁÖ)ÇÏ´Ù;µÞ°ÉÀ½ÁúÄ¡´Ù;°ø¹«´Ï»©´Ù;ÁÖÃã(¿òÂñ)ÇÏ´Ù;µÇƦ;¹Ýµ¿;µÚ·Î ¹Ýµ¿ÇÔ(´ëÆ÷ÀÇ);µÞ°ÉÀ½Áú;À§Ãà;Çø¿À;ÁøÀú¸®Ä§
  • recoilless
    ¹Ýµ¿ÀÌ ÀûÀº(¾ø´Â);ºÎ¹Ýµ¿ÀÇ
  • recoin
    ÀçÁÖÇÏ´Ù
  • recoinage
    °³ÁÖ(È­Æó)
  • recollect
    ȸ»óÇÏ´Ù
  • recollect
    ´Ù½Ã ¸ðÀ¸´Ù;(¸¶À½ µîÀ»)ÁøÁ¤½ÃŰ´Ù;³ÃÁ¤(Ä§Âø)ÇÏ°Ô ÇÏ´Ù;(¿ë±â µîÀ»)´Ù½Ã ºÒ·¯ÀÏÀ¸Å°´Ù;ºÏµ¸¿ì´Ù;´Ù½Ã ¸ðÀ¸´Ù
  • recollect
    »ý°¢ÇØ ³»´Ù;ȸ»óÇÏ´Ù;»ý°¢³ª´Ù;±â¾ï³ª´Ù
  • recollected
    Ä§ÂøÇÑ;Â÷ºÐÇÑ;³ÃÁ¤ÇÑ;»ý°¢³­;Ãß¾ï(ȸ»ó)ÀÇ;¹¬»ó¿¡ Àá±ä;~ly;~ness
  • recollection
    ±â¾ï(·Â); Ãß»ó
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 14
REC in a mutual or shared manner
REC (often followed by `for') in exchange or in reciprocation
REC alternate the direction of motion of
REC act, feel, or give mutually or in return
REC moving alternately backward and forward
REC an internal-combustion engine in which the crankshaft is turned by pistons moving up and down in cylinders
REC mutual interaction
REC alternating back-and-forth movement
REC the act of making and return or doing something in return
REC given or done or owed to each other
REC moving alternately backward and forward
REC mutual exchange of commercial or other privileges
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 14
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
ÅëÇÕ°Ë»ö ¿Ï·á